1	Retrospective	Retrospective	B-NP	JJ	O	3	NMOD	0
2	case	case	I-NP	NN	O	3	NMOD	0
3	series	series	I-NP	NN	O	0	ROOT	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	juxtafoveal	juxtafoveal	B-NP	JJ	O	7	NMOD	0
6	choroidal	choroidal	I-NP	JJ	O	7	NMOD	0
7	neovascularization	neovascularization	I-NP	NN	O	4	PMOD	3	neovascularization
8	treated	treat	B-VP	VBN	O	7	NMOD	19	treated
9	with	with	B-PP	IN	O	8	VMOD	0
10	photodynamic	photodynamic	B-NP	JJ	O	11	NMOD	0
11	therapy	therapy	I-NP	NN	O	9	PMOD	0
12	with	with	B-PP	IN	O	11	NMOD	0
13	verteporfin	verteporfin	B-NP	NN	O	12	PMOD	0
14	.	.	O	.	O	3	P	0

1	PURPOSE	PURPOSE	B-NP	NN	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	To	To	B-VP	TO	O	4	VMOD	0
4	describe	describe	I-VP	VB	O	1	NMOD	0
5	visual	visual	B-NP	JJ	O	6	NMOD	0
6	acuity	acuity	I-NP	NN	O	9	NMOD	0
7	and	and	O	CC	O	9	NMOD	0
8	angiographic	angiographic	B-NP	JJ	O	9	NMOD	0
9	outcomes	outcome	I-NP	NNS	O	4	OBJ	0
10	of	of	B-PP	IN	O	9	NMOD	0
11	juxtafoveal	juxtafoveal	B-NP	JJ	O	13	NMOD	0
12	choroidal	choroidal	I-NP	JJ	O	13	NMOD	0
13	neovascularization	neovascularization	I-NP	NN	O	10	PMOD	3	neovascularization
14	(	(	O	(	O	16	DEP	0
15	CNV	CNV	B-NP	NN	O	16	DEP	3	CNV
16	)	)	O	)	O	13	NMOD	0
17	treated	treat	B-VP	VBN	O	13	NMOD	19	treated
18	with	with	B-PP	IN	O	17	VMOD	0
19	photodynamic	photodynamic	B-NP	JJ	O	20	NMOD	0
20	therapy	therapy	I-NP	NN	O	22	NMOD	0
21	and	and	O	CC	O	22	NMOD	0
22	verteporfin	verteporfin	B-NP	NN	O	18	PMOD	0
23	(	(	O	(	O	25	DEP	0
24	PDT	PDT	B-NP	NN	O	25	DEP	0
25	)	)	O	)	O	22	NMOD	0
26	.	.	O	.	O	4	P	0

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Four	Four	B-NP	CD	O	4	AMOD	0
4	hundred	hundred	I-NP	CD	O	7	NMOD	0
5	eighty-four	eighty-four	I-NP	CD	O	4	AMOD	0
6	consecutive	consecutive	I-NP	JJ	O	7	NMOD	0
7	eyes	eye	I-NP	NNS	O	26	SUB	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	446	446	B-NP	CD	O	10	NMOD	0
10	patients	patient	I-NP	NNS	O	8	PMOD	0
11	treated	treat	B-VP	VBN	O	10	NMOD	19	treated
12	with	with	B-PP	IN	O	11	VMOD	0
13	PDT	PDT	B-NP	NN	O	12	PMOD	0
14	from	from	B-PP	IN	O	13	NMOD	0
15	January	January	B-NP	NNP	O	14	PMOD	0
16	1	1	I-NP	CD	O	15	NMOD	0
17	,	,	I-NP	,	O	15	P	0
18	2001	2001	I-NP	CD	O	15	NMOD	0
19	,	,	O	,	O	15	P	0
20	to	to	B-PP	TO	O	14	PMOD	0
21	June	June	B-NP	NNP	O	20	PMOD	0
22	30	30	I-NP	CD	O	21	NMOD	0
23	,	,	I-NP	,	O	21	P	0
24	2002	2002	I-NP	CD	O	21	NMOD	0
25	,	,	O	,	O	7	P	0
26	were	be	B-VP	VBD	O	1	NMOD	0
27	identified	identify	I-VP	VBN	O	26	VC	0
28	from	from	B-PP	IN	O	27	VMOD	0
29	billing	billing	B-NP	NN	O	30	NMOD	0
30	records	record	I-NP	NNS	O	28	PMOD	0
31	.	.	O	.	O	1	P	0

1	Fluorescein	Fluorescein	B-NP	NN	O	2	NMOD	0
2	angiograms	angiogram	I-NP	NNS	O	3	SUB	0
3	were	be	B-VP	VBD	O	0	ROOT	0
4	reviewed	review	I-VP	VBN	O	3	VC	0
5	retrospectively	retrospectively	B-ADVP	RB	O	7	VMOD	0
6	to	to	B-VP	TO	O	7	VMOD	0
7	identify	identify	I-VP	VB	O	4	VMOD	0
8	juxtafoveal	juxtafoveal	B-NP	JJ	O	9	NMOD	0
9	CNV	CNV	I-NP	NN	O	7	OBJ	3	CNV
10	.	.	O	.	O	3	P	0

1	Eligible	Eligible	B-NP	JJ	O	2	NMOD	0
2	patients	patient	I-NP	NNS	O	3	SUB	0
3	had	have	B-VP	VBD	O	0	ROOT	0
4	CNV	CNV	B-NP	NN	O	3	OBJ	3	CNV
5	in	in	B-PP	IN	O	4	NMOD	0
6	which	which	B-NP	WDT	O	5	PMOD	0
7	the	the	B-NP	DT	O	9	NMOD	0
8	central	central	I-NP	JJ	O	9	NMOD	0
9	boundary	boundary	I-NP	NN	O	5	PMOD	0
10	of	of	B-PP	IN	O	9	NMOD	0
11	the	the	B-NP	DT	O	12	NMOD	0
12	lesion	lesion	I-NP	NN	O	10	PMOD	0
13	was	be	B-VP	VBD	O	3	VMOD	0
14	between	between	B-PP	IN	O	13	PRD	0
15	1	1	B-NP	CD	O	17	AMOD	0
16	and	and	I-NP	CC	O	17	AMOD	0
17	199	199	I-NP	CD	O	18	NMOD	0
18	microm	microm	I-NP	NN	O	14	PMOD	0
19	from	from	B-PP	IN	O	18	NMOD	0
20	the	the	B-NP	DT	O	22	NMOD	0
21	geometric	geometric	I-NP	JJ	O	22	NMOD	0
22	center	center	I-NP	NN	O	19	PMOD	0
23	of	of	B-PP	IN	O	22	NMOD	0
24	the	the	B-NP	DT	O	27	NMOD	0
25	foveal	foveal	I-NP	JJ	O	27	NMOD	0
26	avascular	avascular	I-NP	JJ	O	27	NMOD	0
27	zone	zone	I-NP	NN	O	23	PMOD	0
28	(	(	O	(	O	30	DEP	0
29	FAZ	FAZ	B-NP	NN	B-protein	30	DEP	0
30	)	)	O	)	O	27	NMOD	0
31	.	.	O	.	O	3	P	0

1	Patient	Patient	B-NP	NN	O	2	NMOD	0
2	charts	chart	I-NP	NNS	O	3	SUB	0
3	were	be	B-VP	VBD	O	0	ROOT	0
4	reviewed	review	I-VP	VBN	O	3	VC	0
5	for	for	B-PP	IN	O	4	VMOD	0
6	visual	visual	B-NP	JJ	O	7	NMOD	0
7	acuity	acuity	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	the	the	B-NP	DT	O	11	NMOD	0
10	treated	treat	I-NP	VBN	O	11	NMOD	19	treated
11	eye	eye	I-NP	NN	O	8	PMOD	0
12	before	before	B-PP	IN	O	7	NMOD	0
13	PDT	PDT	B-NP	NN	O	12	PMOD	0
14	and	and	B-PP	CC	O	12	PMOD	0
15	at	at	B-PP	IN	O	12	PMOD	0
16	6-	6-	B-NP	CD	O	20	NMOD	0
17	and	and	O	CC	O	20	NMOD	0
18	12-month	12-month	B-NP	JJ	O	20	NMOD	0
19	follow-up	follow-up	I-NP	JJ	O	20	NMOD	0
20	examinations	examination	I-NP	NNS	O	15	PMOD	0
21	.	.	O	.	O	3	P	0

1	Presence	Presence	B-NP	NN	O	12	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	subfoveal	subfoveal	B-NP	JJ	O	4	NMOD	0
4	CNV	CNV	I-NP	NN	O	2	PMOD	3	CNV
5	at	at	B-PP	IN	O	1	NMOD	0
6	6	6	B-NP	CD	O	9	NMOD	0
7	and	and	I-NP	CC	O	9	NMOD	0
8	12	12	I-NP	CD	O	9	NMOD	0
9	months	month	I-NP	NNS	O	5	PMOD	0
10	of	of	B-PP	IN	O	9	NMOD	0
11	follow-up	follow-up	B-NP	NN	O	10	PMOD	0
12	was	be	B-VP	VBD	O	0	ROOT	0
13	determined	determine	I-VP	VBN	O	12	VC	0
14	by	by	B-PP	IN	O	13	VMOD	0
15	review	review	B-NP	NN	O	14	PMOD	0
16	of	of	B-PP	IN	O	15	NMOD	0
17	fluorescein	fluorescein	B-NP	NN	O	18	NMOD	0
18	angiograms	angiogram	I-NP	NNS	O	16	PMOD	0
19	.	.	O	.	O	12	P	0

1	A	A	B-NP	DT	O	2	NMOD	0
2	lesion	lesion	I-NP	NN	O	3	SUB	0
3	was	be	B-VP	VBD	O	0	ROOT	0
4	considered	consider	I-VP	VBN	O	3	VC	0
5	subfoveal	subfoveal	B-ADJP	JJ	O	4	PRD	0
6	if	if	B-SBAR	IN	O	4	VMOD	0
7	it	it	B-NP	PRP	O	8	SUB	0
8	extended	extend	B-VP	VBD	O	6	SBAR	0
9	underneath	underneath	B-PP	IN	O	8	VMOD	0
10	the	the	B-NP	DT	O	12	NMOD	0
11	geometric	geometric	I-NP	JJ	O	12	NMOD	0
12	center	center	I-NP	NN	O	9	PMOD	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	the	the	B-NP	DT	O	15	NMOD	0
15	FAZ	FAZ	I-NP	NN	B-protein	13	PMOD	0
16	.	.	O	.	O	3	P	0

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Twenty-one	Twenty-one	B-NP	CD	O	4	NMOD	0
4	eyes	eye	I-NP	NNS	O	5	SUB	0
5	had	have	B-VP	VBD	O	1	NMOD	0
6	juxtafoveal	juxtafoveal	B-NP	JJ	O	7	NMOD	0
7	CNV	CNV	I-NP	NN	O	5	OBJ	3	CNV
8	.	.	O	.	O	1	P	0

1	Median	Median	B-NP	JJ	O	2	NMOD	0
2	change	change	I-NP	NN	O	0	ROOT	0
3	in	in	B-PP	IN	O	2	NMOD	0
4	visual	visual	B-NP	JJ	O	5	NMOD	0
5	acuity	acuity	I-NP	NN	O	3	PMOD	0
6	both	both	O	CC	O	10	NMOD	0
7	6	6	B-NP	CD	O	10	NMOD	0
8	and	and	I-NP	CC	O	10	NMOD	0
9	12	12	I-NP	CD	O	10	NMOD	0
10	months	month	I-NP	NNS	O	3	PMOD	0
11	after	after	B-SBAR	IN	O	10	NMOD	0
12	the	the	B-NP	DT	O	14	NMOD	0
13	initial	initial	I-NP	JJ	O	14	NMOD	0
14	PDT	PDT	I-NP	NN	O	15	SUB	0
15	was	be	B-VP	VBD	O	11	SBAR	0
16	0	0	B-NP	CD	O	17	NMOD	0
17	lines	line	I-NP	NNS	O	15	PRD	0
18	(	(	O	(	O	46	DEP	0
19	n	n	B-NP	NN	O	26	NMOD	0
20	=	=	B-VP	SYM	O	19	NMOD	0
21	18	18	B-NP	CD	O	20	AMOD	0
22	at	at	B-PP	IN	O	19	NMOD	0
23	6	6	B-NP	CD	O	24	NMOD	0
24	months	month	I-NP	NNS	O	22	PMOD	0
25	,	,	O	,	O	26	P	0
26	range	range	B-NP	NN	O	33	NMOD	0
27	-14	-14	I-NP	CD	O	26	NMOD	0
28	to	to	B-PP	TO	O	26	NMOD	0
29	+	+	B-NP	SYM	O	31	NMOD	0
30	8	8	I-NP	CD	O	31	NMOD	0
31	lines	line	I-NP	NNS	O	28	PMOD	0
32	;	;	O	:	O	33	P	0
33	n	n	B-NP	NN	O	40	NMOD	0
34	=	=	B-VP	SYM	O	33	NMOD	0
35	17	17	B-NP	CD	O	34	AMOD	0
36	at	at	B-PP	IN	O	33	NMOD	0
37	12	12	B-NP	CD	O	38	NMOD	0
38	months	month	I-NP	NNS	O	36	PMOD	0
39	,	,	O	,	O	40	P	0
40	range	range	B-NP	NN	O	46	DEP	0
41	-18	-18	I-NP	CD	O	40	NMOD	0
42	to	to	B-PP	TO	O	40	NMOD	0
43	+	+	B-NP	SYM	O	45	NMOD	0
44	7	7	I-NP	CD	O	45	NMOD	0
45	lines	line	I-NP	NNS	O	42	PMOD	0
46	)	)	O	)	O	17	NMOD	0
47	.	.	O	.	O	2	P	0

1	Eleven	Eleven	B-NP	CD	O	2	NMOD	0
2	lesions	lesion	I-NP	NNS	O	3	SUB	0
3	progressed	progress	B-VP	VBD	O	0	ROOT	2	progressed
4	to	to	B-PP	TO	O	3	VMOD	0
5	a	a	B-NP	DT	O	7	NMOD	0
6	subfoveal	subfoveal	I-NP	JJ	O	7	NMOD	0
7	location	location	I-NP	NN	O	4	PMOD	0
8	by	by	B-PP	IN	O	7	NMOD	0
9	12	12	B-NP	CD	O	10	NMOD	0
10	months	month	I-NP	NNS	O	8	PMOD	0
11	.	.	O	.	O	3	P	0

1	Visual	Visual	B-NP	JJ	O	2	NMOD	0
2	acuity	acuity	I-NP	NN	O	8	SUB	0
3	in	in	B-PP	IN	O	2	NMOD	0
4	eyes	eye	B-NP	NNS	O	3	PMOD	0
5	with	with	B-PP	IN	O	4	NMOD	0
6	progressive	progressive	B-NP	JJ	O	7	NMOD	0
7	lesions	lesion	I-NP	NNS	O	5	PMOD	0
8	decreased	decrease	B-VP	VBD	O	0	ROOT	0
9	a	a	B-NP	DT	O	10	NMOD	0
10	median	median	I-NP	NN	O	8	OBJ	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	4	4	B-NP	CD	O	13	NMOD	0
13	lines	line	I-NP	NNS	O	11	PMOD	0
14	of	of	B-PP	IN	O	13	NMOD	0
15	vision	vision	B-NP	NN	O	14	PMOD	0
16	.	.	O	.	O	8	P	0

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Despite	Despite	B-PP	IN	O	16	VMOD	0
4	a	a	B-NP	DT	O	7	NMOD	0
5	small	small	I-NP	JJ	O	7	NMOD	0
6	sample	sample	I-NP	NN	O	7	NMOD	0
7	size	size	I-NP	NN	O	10	NMOD	0
8	and	and	I-NP	CC	O	10	NMOD	0
9	limited	limited	I-NP	JJ	O	10	NMOD	0
10	length	length	I-NP	NN	O	3	PMOD	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	follow-up	follow-up	B-NP	NN	O	11	PMOD	0
13	,	,	O	,	O	16	P	0
14	this	this	B-NP	DT	O	15	NMOD	0
15	study	study	I-NP	NN	O	16	SUB	0
16	shows	show	B-VP	VBZ	O	1	NMOD	0
17	that	that	B-SBAR	IN	O	16	VMOD	0
18	visual	visual	B-NP	JJ	O	19	NMOD	0
19	acuity	acuity	I-NP	NN	O	22	SUB	0
20	on	on	B-PP	IN	O	19	NMOD	0
21	average	average	B-NP	NN	O	20	PMOD	0
22	can	can	B-VP	MD	O	17	SBAR	0
23	remain	remain	I-VP	VB	O	22	VC	0
24	stable	stable	B-ADJP	JJ	O	23	PRD	0
25	for	for	B-PP	IN	O	24	AMOD	0
26	at	at	B-NP	IN	O	29	NMOD	0
27	least	least	I-NP	JJS	O	26	AMOD	0
28	12	12	I-NP	CD	O	26	AMOD	0
29	months	month	I-NP	NNS	O	25	PMOD	0
30	after	after	B-PP	IN	O	29	NMOD	0
31	PDT	PDT	B-NP	NN	O	30	PMOD	0
32	of	of	B-PP	IN	O	31	NMOD	0
33	juxtafoveal	juxtafoveal	B-NP	JJ	O	34	NMOD	0
34	lesions	lesion	I-NP	NNS	O	32	PMOD	0
35	.	.	O	.	O	1	P	0

1	Growth	Growth	B-NP	NN	O	7	SUB	0
2	through	through	B-PP	IN	O	1	NMOD	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	foveal	foveal	I-NP	JJ	O	5	NMOD	0
5	center	center	I-NP	NN	O	2	PMOD	0
6	still	still	B-ADVP	RB	O	7	VMOD	0
7	can	can	B-VP	MD	O	14	VMOD	0
8	occur	occur	I-VP	VB	O	7	VC	0
9	,	,	O	,	O	8	P	0
10	however	however	B-ADVP	RB	O	8	VMOD	0
11	,	,	O	,	O	14	P	0
12	and	and	O	CC	O	14	VMOD	0
13	this	this	B-NP	DT	O	14	SUB	0
14	can	can	B-VP	MD	O	0	ROOT	0
15	be	be	I-VP	VB	O	14	VC	0
16	associated	associate	I-VP	VBN	O	15	VC	0
17	with	with	B-PP	IN	O	16	VMOD	0
18	substantial	substantial	B-NP	JJ	O	20	NMOD	0
19	visual	visual	I-NP	JJ	O	20	NMOD	0
20	loss	loss	I-NP	NN	O	17	PMOD	0
21	.	.	O	.	O	14	P	0

